Tazarotene Gel
Product Images NDC 45802-442

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 45802-442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure of tazarotene, a retinoid compound depicted with its molecular arrangement including a thiophene ring, pyridine ring, and an ester functional group.*
FDA Label Image

6y9-carton (Image 02)

6y9-carton (Image 02)
Packaging label for Tazarotene Gel 0.05%, a topical gel for dermatologic use only, not for ophthalmic use. The package contains 100 g of gel and is labeled for prescription use only. Manufactured by Perrigo, made in Israel, with directions and ingredient details printed on the label.*
FDA Label Image

Serialization (Image 03)

Serialization (Image 03)
A label panel for TAZAROTENE topical gel showing placeholders for serial number (S/N), lot number, and expiration date (Exp) to be inserted. The label is a black text on white background within a rectangular border.*
FDA Label Image

7e6-carton (Image 04)

7e6-carton (Image 04)
Packaging label for Tazarotene Gel 0.1%, 100 g topical gel. The label states it is for dermatologic use only and not for ophthalmic use. Manufactured and distributed by Perrigo in Israel. Includes dosage and storage instructions along with the list of inactive ingredients and preservative information.*
FDA Label Image

Serialization-2 (Image 05)

Serialization-2 (Image 05)
The image shows a black-bordered box containing placeholder text for serial number, lot number, and expiration date fields on a label. It is intended for TAZAROTENE topical gel packaging, provided by Padagis Israel Pharmaceuticals Ltd. No specific numeric or date information is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.